Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,736.40
(
1.03%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
111.00
(
0.59%
)
Bitcoin
77,412.00
(
1.42%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 247642

Wednesday, 06/21/2023 7:32:45 PM

Wednesday, June 21, 2023 7:32:45 PM

Post# of 257473

…[GSK] factored [biannual dosing] into the new pricing.

I’m not sure GSK (or PFE or MRNA) can offset the effect of biannual (rather than annual) dosing by simply raising the price per dose. Annual dosing, as with flu vaccines, establishes a routine that leads to relatively high compliance. Biannual dosing doesn’t work as well in that regard.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today